NEKTAR THERAPEUTICS (NKTR) Insider Trading -- Recent Executive & Director Transactions

3 insiders reported 44 Form 4 transactions for NEKTAR THERAPEUTICS (NKTR) over the past 18 months (most recent 2026-05-21). Recent activity: ROBIN HOWARD W (President & CEO) Sell 444 shares, Zalevsky Jonathan (Chief R&D Officer) Sell 199 shares, Zalevsky Jonathan (Chief R&D Officer) Sell 180 shares, ROBIN HOWARD W (President & CEO) Sell 423 shares, Zalevsky Jonathan (Chief R&D Officer) Sell 3,867 shares. Source: SEC Form 4.

DateInsiderTitleTypeSharesValue
2026-05-21ROBIN HOWARD WPresident & CEOSell444$29,086
2026-05-21Zalevsky JonathanChief R&D OfficerSell199$13,036
2026-02-20Zalevsky JonathanChief R&D OfficerSell180$13,140
2026-02-20ROBIN HOWARD WPresident & CEOSell423$30,879
2026-01-22Zalevsky JonathanChief R&D OfficerSell3,867$137,936
2025-12-23ROBIN HOWARD WPresident & CEOBuy21,667$0
2025-12-23Zalevsky JonathanChief R&D OfficerBuy6,250$0
2025-11-25Zalevsky JonathanChief R&D OfficerSell1,157$62,802
2025-11-25Wilson Mark AndrewChief Legal OfficerSell630$34,196
2025-11-25ROBIN HOWARD WPresident & CEOBuy7,110$0
2025-11-25ROBIN HOWARD WPresident & CEOSell2,207$119,796
2025-11-25Zalevsky JonathanChief R&D OfficerBuy2,666$0
2025-11-25Wilson Mark AndrewChief Legal OfficerBuy1,903$0
2025-09-11ROBIN HOWARD WPresident & CEOSell2,100$94,836
2025-09-11ROBIN HOWARD WPresident & CEOSell1,200$55,692
2025-09-11ROBIN HOWARD WPresident & CEOSell2,156$102,388
2025-09-11ROBIN HOWARD WPresident & CEOSell1,210$58,298
2025-09-08ROBIN HOWARD WPresident & CEOSell1,923$62,248
2025-09-08ROBIN HOWARD WPresident & CEOSell1,496$50,176
2025-09-08ROBIN HOWARD WPresident & CEOSell613$21,087
2025-09-08ROBIN HOWARD WPresident & CEOSell1,134$40,597
2025-09-08ROBIN HOWARD WPresident & CEOSell3,304$125,122
2025-09-08ROBIN HOWARD WPresident & CEOSell2,226$86,413
2025-09-08ROBIN HOWARD WPresident & CEOSell1,136$45,315
2025-09-08Zalevsky JonathanChief R&D OfficerSell793$25,717

Source: SEC Form 4 filings · as of 2026-05-21